CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹36,742 Cr | ₹32,130 Cr | ₹29,007 Cr | ₹26,652 Cr | ₹24,837 Cr |
What is the latest Total Liabilities ratio of CIPLA ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹36,742 Cr |
| Mar2024 | ₹32,130 Cr |
| Mar2023 | ₹29,007 Cr |
| Mar2022 | ₹26,652 Cr |
| Mar2021 | ₹24,837 Cr |
How is Total Liabilities of CIPLA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹36,742 Cr | 14.35 | |
| Mar2024 | ₹32,130 Cr | 10.77 | |
| Mar2023 | ₹29,007 Cr | 8.83 | |
| Mar2022 | ₹26,652 Cr | 7.31 | |
| Mar2021 | ₹24,837 Cr | - | |
Compare Total Liabilities of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹121,456.8 Cr | -4.9% | -0.8% | 6.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,147.0 Cr | -1.4% | 3.6% | -7.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,488.0 Cr | 4.4% | 15.9% | 15.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,057.0 Cr | -0.6% | 1.8% | 15.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,220.0 Cr | -4.1% | -3.8% | -4.3% | Stock Analytics | |
| MANKIND PHARMA | ₹97,796.9 Cr | -3.1% | -3.3% | -8.6% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | -4.9% |
-0.8% |
6.6% |
| SENSEX | -1.4% |
3.1% |
3.8% |
You may also like the below Video Courses